Caroline Landau

Co-Founder & COO at Refractal

Caroline joined Refractal from Genentech, where she focused on marketing, forecasting, and brand strategy for cutting edge treatments within neurological diseases, lung cancer, and other diseases impacting thousands of people each year. Caroline is an MBA graduate of the University of Michigan’s Ross School of Business and completed her undergraduate studies at Brown University. Caroline is a Fulbright Fellow, a recipient of the University of Michigan Social Entrepreneurship Leadership Award, and a Helen Huff Scholar at UM Center for the Education of Women.


Org chart


Teams


Offices

This person is not in any offices


Refractal

PreDxion Bio is an early-stage healthcare company based in South San Francisco that is developing a highly scalable sensor platform (10M+ tests/day) to detect viruses and proteins, with particular emphasis on SARS-CoV-2 and biomarkers (immune markers).